Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study

Detalles Bibliográficos
Autores principales: Ciresi, Alessandro, Vigneri, Enrica, Radellini, Stefano, Pantò, Felicia, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984926/
https://www.ncbi.nlm.nih.gov/pubmed/29637460
http://dx.doi.org/10.1007/s13300-018-0423-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984926/
https://www.ncbi.nlm.nih.gov/pubmed/29637460
http://dx.doi.org/10.1007/s13300-018-0423-3

Ejemplares similares